Adverse immunostimulation caused by impurities: The dark side of biopharmaceuticals-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adverse immunostimulation caused by impurities: The dark side of biopharmaceuticals

Published:2019-05-29 Issue:7 Volume:85 Page:1418-1426
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Reijers Joannes A. A.¹^ORCID,Malone Karen E.²,Bajramovic Jeffrey J.³,Verbeek Richard⁴,Burggraaf Jacobus¹,Moerland Matthijs¹

Affiliation:

1. Centre for Human Drug Research Leiden the Netherlands

2. Sagacity Leiden the Netherlands

3. Alternatives UnitBiomedical Primate Research Centre Rijswijk the Netherlands

4. Department of Clinical Pharmacy and ToxicologyLeiden University Medical Center Leiden the Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.13938

Reference61 articles.

1. Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412

2. US Food and Drug Administration.Immunotoxicology evaluation of investigational new drugs. US Department of Health and Human Services.2002.

3. Adverse side-effects to biological agents

4. Allergic host defences

5. Mast Cells and Anaphylaxis

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rationalisation of the purification process for a phage active pharmaceutical ingredient;European Journal of Pharmaceutics and Biopharmaceutics;2024-10

2. Advancements in Nanoparticle Characterization;Methods in Molecular Biology;2024

3. Immunoinformatic Risk Assessment of Host Cell Proteins During Process Development for Biologic Therapeutics;The AAPS Journal;2023-09-11

4. Thermostable chaperone-based polypeptide biosynthesis: Enfuvirtide model product quality and protocol-related impurities;PLOS ONE;2023-06-08

5. Immunogenicity Study of Biosimilar Candidates;Drug Development and Safety [Working Title];2023-02-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3